Esmat Mirabzadeh

515 total citations
31 papers, 384 citations indexed

About

Esmat Mirabzadeh is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Esmat Mirabzadeh has authored 31 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Esmat Mirabzadeh's work include Monoclonal and Polyclonal Antibodies Research (4 papers), vaccines and immunoinformatics approaches (3 papers) and HER2/EGFR in Cancer Research (3 papers). Esmat Mirabzadeh is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), vaccines and immunoinformatics approaches (3 papers) and HER2/EGFR in Cancer Research (3 papers). Esmat Mirabzadeh collaborates with scholars based in Iran, Australia and United Kingdom. Esmat Mirabzadeh's co-authors include Vahid Khalaj, Mohammad Azizi, Ehsan Mostafavi, Mohammad Reza Pourshafie, Shahindokht Bassiri‐Jahromi, Yeganeh Talebkhan, Soroush Sardari, Jila Sadighi, Farzad Katiraee and Elham Bayat and has published in prestigious journals such as Scientific Reports, Frontiers in Microbiology and Toxicon.

In The Last Decade

Esmat Mirabzadeh

28 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esmat Mirabzadeh Iran	12	156	51	49	47	39	31	384
Xiaoyu Zhu China	14	239 1.5×	23 0.5×	73 1.5×	31 0.7×	39 1.0×	25	684
Ruili Zhao China	10	160 1.0×	37 0.7×	30 0.6×	29 0.6×	45 1.2×	40	411
Nestor Ishimwe China	7	216 1.4×	61 1.2×	30 0.6×	122 2.6×	31 0.8×	9	385
Bridget Graves United States	8	140 0.9×	48 0.9×	81 1.7×	34 0.7×	24 0.6×	10	397
Kah Yan How Malaysia	6	217 1.4×	16 0.3×	72 1.5×	59 1.3×	22 0.6×	9	679
Mohammad Reza Akbari Eidgahi Iran	12	198 1.3×	15 0.3×	51 1.0×	41 0.9×	40 1.0×	28	392
Marlene Barros Portugal	14	194 1.2×	74 1.5×	12 0.2×	42 0.9×	48 1.2×	46	458
Mohammed Ali Bakkari Saudi Arabia	9	99 0.6×	23 0.5×	74 1.5×	37 0.8×	12 0.3×	24	330
Zhaobin Wang China	13	143 0.9×	56 1.1×	16 0.3×	92 2.0×	35 0.9×	25	444
Won‐Gi Bang South Korea	11	269 1.7×	59 1.2×	37 0.8×	33 0.7×	165 4.2×	24	629

Countries citing papers authored by Esmat Mirabzadeh

Since Specialization

Citations

This map shows the geographic impact of Esmat Mirabzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmat Mirabzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmat Mirabzadeh more than expected).

Fields of papers citing papers by Esmat Mirabzadeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmat Mirabzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmat Mirabzadeh. The network helps show where Esmat Mirabzadeh may publish in the future.

Co-authorship network of co-authors of Esmat Mirabzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Esmat Mirabzadeh. A scholar is included among the top collaborators of Esmat Mirabzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esmat Mirabzadeh. Esmat Mirabzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Talebkhan, Yeganeh, Elham Bayat, Alireza Biglari, et al.. (2024). A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. AMB Express. 14(1). 19–19. 3 indexed citations

Torkashvand, Fatemeh, et al.. (2023). Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties. 27(2). 108–116.

Gholami, Parisa, Elham Bayat, Yeganeh Talebkhan, et al.. (2023). Expression, Purification, and Biological Evaluation of XTEN-GCSF in a Neutropenic Rat Model. Applied Biochemistry and Biotechnology. 196(2). 804–820. 3 indexed citations

Badmasti, Farzad, et al.. (2023). Enhanced anti-biofilm activity of the minocycline-and-gallium-nitrate using niosome wrapping against Acinetobacter baumannii in C57/BL6 mouse pneumonia model. International Immunopharmacology. 115. 109551–109551. 11 indexed citations

Ajdary, Soheila, Esmat Mirabzadeh, Elnaz Agi, et al.. (2022). Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytes. Pathogens and Disease. 80(1). 5 indexed citations

Mirabzadeh, Esmat, Jila Sadighi, Saeed Farzad‐Mohajeri, et al.. (2021). Guideline for the Care and Use of Laboratory Animals in Iran. Lab Animal. 50(11). 303–305. 60 indexed citations

Taromchi, Amir Hossein, et al.. (2021). Induction of Immunogenic Response in BALB/c Mice by Live and Killed Form of Recombinant Lactococcus lactis Displaying EG95 of Echinococcus granulosus. Iranian Biomedical Journal. 25(4). 284–296. 3 indexed citations

Mirabzadeh, Esmat, et al.. (2021). Expression of a Novel HIV-1 Gag-Pol-Env-Nef-Rev Multi-Epitope Construct in Escherichia coli. 9(2). 62–70. 1 indexed citations

Torkashvand, Fatemeh, Seyed Nasser Ostad, Mehdi Mirzaie, et al.. (2020). Proteomics Analysis of Trastuzumab Toxicity in the H9c2 Cardiomyoblast Cell Line and its Inhibition by Carvedilol. Current Pharmaceutical Biotechnology. 21(13). 1377–1385. 1 indexed citations

10.

Talebkhan, Yeganeh, Fereidoun Mahboudi, Reza Ahangari Cohan, et al.. (2020). Improvement of Certolizumab Fab′ properties by PASylation technology. Scientific Reports. 10(1). 18464–18464. 19 indexed citations

11.

Taromchi, Amir Hossein, et al.. (2020). Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice. Probiotics and Antimicrobial Proteins. 13(1). 80–89. 21 indexed citations

12.

Siadat, Seyed Davar, et al.. (2019). Evaluation of antibody responses to outer membrane vesicles (OMVs) and killed whole cell of Vibrio cholerae O1 El Tor in immunized mice. Iranian Journal of Microbiology. 11(3). 212–219. 18 indexed citations

13.

Alikhani, Mehdi, et al.. (2019). The Inhibitory Effect of Mouse Gastric DNA on Amplification of Helicobacter pylori Genomic DNA in Quantitative PCR. Iranian Biomedical Journal. 23(4). 297–302. 1 indexed citations

14.

Siadat, Seyed Davar, et al.. (2018). Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice. 5(2). 47–51.

15.

Rouini, Mohammad Reza, Esmat Mirabzadeh, Behrouz Vaziri, et al.. (2017). Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats. Scientific Reports. 7(1). 43028–43028. 5 indexed citations

16.

Talebkhan, Yeganeh, et al.. (2016). Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha.. PubMed. 8(1). 21–8. 6 indexed citations

17.

Mirabzadeh, Esmat, et al.. (2015). Evaluation of Effectiveness of Honey-Based Alginate Hyrogel on Wound Healing in a Mouse Model of Rat. 2(3). 293–297. 10 indexed citations

18.

Ghaemi, Nasser, et al.. (2014). Cloning and expression of Aspergillus flavus urate oxidase in Pichia pastoris. SpringerPlus. 3(1). 395–395. 25 indexed citations

19.

Nasiri, Shirzad, et al.. (2014). RABBIT PYROGEN TEST STUDY OF INFUSIBLE PLATELET MEMBRANE AS A PLATELET SUBSTITUTE FOR BLOOD TRANSFUSION. Journal of Drug Delivery and Therapeutics. 4(6). 1 indexed citations

20.

Jamili, Shahla, et al.. (2013). The first report on some toxic effects of green scat, Scatophagus argus an Iranian Persian Gulf venomous fish. Toxicon. 66(5323). 82–87. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact